J Korean Soc Neonatol.  2008 Nov;15(2):142-150.

Comparison of the Therapeutic Effects of Curosurf(R) and Newfactan(R) in Respiratory Distress Syndrome

Affiliations
  • 1Department of Pediatrics, Eulji University School of Medicine, Daejeon, Korea. phojin71@eulji.ac.kr

Abstract

PURPOSE
The aim of this study was to compare the clinical effects of modified porcine (Curosurf(R)) and bovine (Newfactan(R)) surfactants in the treatment of neonatal respiratory distress syndrome.
METHODS
Between April 2004 and December 2006, 65 neonates (birth weight < or =2,500 g and gestational age < or =35 weeks) with neonatal respiratory distress syndrome were treated in our neonatal intensive care unit with surfactant. Thirty-one neonates received Curosurf(R) and 34 neonates received Newfactan(R). The neonates were not enrolled if they had major congenital anomalies or meconium aspiration syndrome. We compared the changes in respiratory parameters after surfactant instillation, the incidences of acute and chronic complications, and the mortality between the two treatment groups.
RESULTS
Neonatal and maternal demographic characteristics were not different between the groups. The patterns of change in the respiratory parameters after surfactant instillation were not statistically different between the groups. The incidences of surfactant reinstillation and acute complications, such as pneumothorax, patent ductus arteriosus, pulmonary hemorrhage, and grade 3-4 intraventricular hemorrhage, were not different between the neonates who received Curosurf(R) and the neonates who received Newfactan(R). There were no statistically significant differences in the duration of mechanical ventilation, oxygen therapy, hospitalization, prevalence of bronchopulmonary dysplasia, periventricular leukomalacia, retinopathy of prematurity, necrotizing enterocolitis, and mortality between the groups.
CONCLUSION
In the present comparative study, no significant differences in the clinical effects of Curosurf(R) and Newfactan(R) were observed.

Keyword

Curosurf(R); Newfactan(R); Respiratory distress syndrome; Surfactant treatment

MeSH Terms

Bronchopulmonary Dysplasia
Ductus Arteriosus, Patent
Enterocolitis, Necrotizing
Gestational Age
Hemorrhage
Hospitalization
Humans
Incidence
Infant, Newborn
Intensive Care, Neonatal
Leukomalacia, Periventricular
Meconium Aspiration Syndrome
Oxygen
Pneumothorax
Prevalence
Respiration, Artificial
Respiratory Distress Syndrome, Newborn
Retinopathy of Prematurity
Surface-Active Agents
Oxygen
Surface-Active Agents
Full Text Links
  • JKSN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr